What is prion disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prion Disease: A Rare and Fatal Neurodegenerative Disorder

Prion disease is a rare, fatal neurodegenerative disorder caused by the misfolding of prion proteins in the brain, leading to rapid cognitive decline with an invariably fatal outcome and no effective treatments currently available. 1

Definition and Pathophysiology

Prion diseases are characterized by:

  • Abnormal misfolding of the normal prion protein (PrP or PrPc) into pathological conformers called prions (PrPSc) that act as templates for further protein misfolding 1
  • Accumulation of these misfolded proteins in the brain causing neurodegeneration with characteristic spongiform changes in brain tissue 1
  • Self-propagation of the misfolded proteins, which can spread from cell to cell throughout the brain 2

Epidemiology

  • Incidence of 1-2 cases per million population per year 1
  • Accounts for approximately 1 in 6000 deaths 1
  • Most cases occur in individuals between 55-75 years of age 1

Classification and Types

Prion diseases occur in three main forms:

1. Sporadic (85% of cases)

  • Most common form with no known genetic or environmental trigger 1
  • Includes sporadic Creutzfeldt-Jakob disease (CJD) 3

2. Genetic (10-15% of cases)

  • Caused by autosomal dominant protein-altering variants in the PRNP gene located on chromosome 20p13 1
  • Main types include:
    • Genetic Creutzfeldt-Jakob disease
    • Gerstmann-Sträussler-Scheinker syndrome (GSS)
    • Fatal familial insomnia (FFI) 1, 3
  • Most common pathogenic variants include E200K, P102L, D178N, and various octapeptide repeat insertions 1

3. Acquired (rare)

  • Includes variant CJD (linked to bovine spongiform encephalopathy or "mad cow disease"), iatrogenic CJD, and kuru 3, 4
  • Transmission occurs through exposure to infected tissues via ingestion, injection, or transplantation 2

Clinical Presentation

  • Rapidly progressive dementia is the hallmark presentation, especially in sporadic CJD 1
  • Early symptoms vary widely but typically progress to profound cognitive impairment 1
  • Median survival of approximately 5 months for sporadic CJD 1
  • Other common symptoms include:
    • Myoclonic jerks
    • Ataxia
    • Akinetic mutism (late stage)
    • Visual disturbances 1, 3
  • Some genetic forms may progress more slowly over decades 3

Diagnosis

Diagnosis is multifactorial and includes:

  • Clinical history and neurological examination 1
  • Magnetic resonance imaging (MRI) - preferred over CT for detecting characteristic patterns 1, 5
  • Cerebrospinal fluid analysis for:
    • Real-time quaking-induced conversion assay (RT-QuIC) - offers >90% sensitivity and specificity 1, 5
    • 14-3-3 protein
    • Tau protein 1
  • Electroencephalography (EEG) 1
  • Genetic testing for PRNP mutations, particularly important even without apparent family history 1
  • Definitive diagnosis requires neuropathological examination of brain tissue, though this is rarely performed antemortem 4, 5

Treatment and Prognosis

  • Currently no effective treatments that significantly alter disease progression 5
  • All prion diseases are ultimately fatal 4
  • Clinical trials to date have failed to show survival benefit 3
  • Early diagnosis remains important for:
    • Patient care planning
    • Infection control measures
    • Genetic counseling for families 5

Special Considerations

  • Prions are uniquely resistant to normal decontamination procedures, requiring special infection control protocols 4
  • More than half of genetic cases lack a documented family history due to:
    • De novo mutations
    • Incomplete penetrance
    • Misdiagnosis in previous generations
    • Early death from other causes 1
  • Genetic counseling should be offered to all families with a case of prion disease, regardless of apparent family history 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recent advances in the histo-molecular pathology of human prion disease.

Brain pathology (Zurich, Switzerland), 2019

Research

Prion Diseases.

Continuum (Minneapolis, Minn.), 2015

Research

Prionic diseases.

Arquivos de neuro-psiquiatria, 2013

Research

Human prion diseases: An overview.

Medicina clinica, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.